ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 118 filers reported holding ZAI LAB LTD in Q3 2023. The put-call ratio across all filers is 6.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,168,509 | +184.0% | 48,067 | +288.6% | 0.00% | +200.0% |
| Q1 2023 | $411,426 | +126104.3% | 12,370 | +16.3% | 0.00% | 0.0% |
| Q4 2022 | $326 | -99.9% | 10,638 | -19.0% | 0.00% | 0.0% |
| Q2 2022 | $454,000 | +15.2% | 13,136 | +51.5% | 0.00% | 0.0% |
| Q1 2022 | $394,000 | -34.4% | 8,668 | -9.4% | 0.00% | -50.0% |
| Q4 2021 | $601,000 | -94.7% | 9,568 | -91.0% | 0.00% | -92.9% |
| Q3 2021 | $11,368,000 | +28.4% | 106,279 | +113.5% | 0.03% | +21.7% |
| Q2 2021 | $8,854,000 | +642.2% | 49,777 | +439.9% | 0.02% | +666.7% |
| Q1 2021 | $1,193,000 | -39.8% | 9,220 | -37.7% | 0.00% | 0.0% |
| Q4 2020 | $1,983,000 | +106.6% | 14,790 | +27.5% | 0.00% | +50.0% |
| Q3 2020 | $960,000 | +31.5% | 11,600 | +30.3% | 0.00% | -33.3% |
| Q2 2020 | $730,000 | +111.6% | 8,900 | +32.8% | 0.00% | +200.0% |
| Q1 2020 | $345,000 | – | 6,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |